We are live on ! Find out more
KURA icon

Kura Oncology
KURA

14 hedge funds and large institutions have $86.1M invested in Kura Oncology in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+14
Holders Change %
–
% of All Funds
0.37%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
14
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$24.5M
2
EC
EcoR1 Capital
California
+$19.3M
3
PHS
PFM Health Sciences
California
+$11.8M
4
CCP
Clough Capital Partners
Massachusetts
+$8.56M
5
Franklin Resources
Franklin Resources
California
+$7.64M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$26.2M +$24.5M +3,113,719 New
EC
2
EcoR1 Capital
California
$20.6M +$19.3M +2,450,000 New
PHS
3
PFM Health Sciences
California
$12.6M +$11.8M +1,494,169 New
CCP
4
Clough Capital Partners
Massachusetts
$9.13M +$8.56M +1,087,233 New
Franklin Resources
5
Franklin Resources
California
$8.15M +$7.64M +970,171 New
BC
6
Boxer Capital
California
$5.5M +$5.15M +654,595 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.9M +$1.78M +225,667 New
BC
8
Birchview Capital
Vermont
$884K +$829K +105,285 New
MIM
9
Monashee Investment Management
Massachusetts
$548K +$513K +65,222 New
PIM
10
Partner Investment Management
California
$409K +$384K +48,748 New
KP
11
Kiski Partners
New York
$250K +$234K +29,780 New
TRCT
12
Tower Research Capital (TRC)
New York
$9K +$8.04K +1,022 New
BFA
13
BlackRock Fund Advisors
California
$7K +$6.75K +858 New
PCM
14
Prelude Capital Management
New York
$3K +$3.15K +400 New

KURA Hedge Fund Activity: Q4 2015 in Review

14 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2015, worth a combined $86.1M.

Buyers outnumbered sellers: 14 funds opened new KURA positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $24.5M.

  • 14 institutional investors held Kura Oncology (KURA) as of Q4 2015, up from 0 in Q3 2015.
  • Funds reported $86.1M of Kura Oncology stock for Q4 2015.
  • 14 funds opened new Kura Oncology positions in Q4 2015 and 0 closed out, a net change of +14 holders.
  • The largest Kura Oncology buyer in Q4 2015 was Fidelity Investments, an estimated $24.5M added.

Based on aggregated 13F filings for Q4 2015.